Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 mass balance and pharmacokinetics of [14C]TAS-205 in healthy volunteers
jRCT2071210008Phase 1Completed
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pizuglanstat in Duchenne muscular dystrophy (DMD), sponsored by Taiho Pharmaceutical Co., Ltd. Started May 2021; status: completed.
02
Drugs
pizuglanstat
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on jRCT2071210008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071210008.